Skip to main content

Publisher: Elsevier

Volume 9, Number 14, 19 July 1999

Solid phase synthesis of quinolones
pp. 1885-1888(4)
Authors: Srivastava, S.K.; Haq, W.; Murthy, P.K.; Chauhan, P.M.S.

Favourites:
ADD

Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid
pp. 1889-1894(6)
Authors: Assefa, H.; Nimrod, A.; Walker, L.; Sindelar, R.

Favourites:
ADD

Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling
pp. 1895-1900(6)
Authors: Sabb, A.L.; Husbands, G.M.; Tokolics, J.; Stein, R.P.; Tasse, R.P.; Boast, C.A.; Moyer, J.A.; Abou-Gharbia, M.

Favourites:
ADD

Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping
pp. 1901-1906(6)
Authors: Brouillette, W.J.; Atigadda, V.R.; Luo, M.; Air, G.M.; Babu, Y.S.; Bantia, S.

Favourites:
ADD

Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K
pp. 1907-1910(4)
Authors: Duffy, K.J.; Ridgers, L.H.; desJarlais, R.L.; Tomaszek, T.A.; Bossard, M.J.; Thompson, S.K.; Keenan, R.M.; Veber, D.F.

Favourites:
ADD

Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist
pp. 1915-1920(6)
Authors: Moe, S.T.; Shimizu, S.M.; Smith, D.L.; van Wagenen, B.C.; delMar, E.G.; Balandrin, M.F.; Chien, Y.; Raszkiewicz, J.L.; Artman, L.D.; Mueller, A.L.; Lobkovsky, E.; Clardy, J.

Favourites:
ADD

Prodrugs of CL316243: a selective 3-adrenergic receptor agonist for treating obesity and diabetes
pp. 1921-1926(6)
Authors: Sum, F.W.; Gilbert, A.; Venkatesan, A.M.; Lim, K.; Wong, V.; O'dell, M.; Francisco, G.; Chen, Z.; Grosu, G.; Baker, J.; Ellingboe, J.; Malamas, M.; Gunawan, I.; Primeau, J.; Largis, E.; Steiner, K.

Favourites:
ADD

The design and synthesis of ALS inhibitors from pharmacophore models
pp. 1927-1932(6)
Authors: Liu, J.; Li, Z.; Yan, H.; Wang, L.; Chen, J.

Favourites:
ADD

Design and synthesis of amidino-tyrosine derivatives as non-peptide fibrinogen receptor antagonists
pp. 1933-1936(4)
Authors: Xu, T.; Jiang, X.; Hua, W.; Ni, P.; Pei, Y.

Favourites:
ADD

Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells
pp. 1937-1940(4)
Authors: Matsumoto, Y.; Kato, T.; Iseki, S.; Suzuki, H.; Nakano, K.; Iwahara, M.; Ueoka, R.

Favourites:
ADD

Synthesis of probes for the active site of leucine dehydrogenase
pp. 1941-1944(4)
Authors: Sutherland, A.; Willis, C.L.

Favourites:
ADD

Effects of ortho-substituent groups of sulochrin on inhibitory activity to eosinophil degranulation
pp. 1945-1948(4)
Authors: Ohashi, H.; Ueno, A.; Nakao, T.; Ito, J.; Kimura, K.; Ishikawa, M.; Kawai, H.; Iijima, H.; Osawa, T.

Favourites:
ADD

Isolation and structure of SCH 351633: a novel hepatitis C virus (HCV) NS3 protease inhibitor from the fungus penicillium griseofulvum
pp. 1949-1952(4)
Authors: Chu, M.; Mierzwa, R.; He, L.; King, A.; Patel, M.; Pichardo, J.; Hart, A.; Butkiewicz, N.; Puar, M.S.

Favourites:
ADD

Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazepine AMPA antagonists
pp. 1953-1956(4)
Authors: Anderson, B.A.; Harn, N.K.; Hansen, M.M.; Harkness, A.R.; Lodge, D.; Leander, J.D.

Favourites:
ADD
Favourites:
ADD

Structure-based design of a non-peptidic antagonist of the SH2 domain of GRB2
pp. 1973-1978(6)
Authors: Caravatti, G.; Rahuel, J.; Gay, B.; Furet, P.

Favourites:
ADD

Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist
pp. 1979-1984(6)
Authors: Kuroda, S.; Akahane, A.; Itani, H.; Nishimura, S.; Durkin, K.; Kinoshita, T.; Tenda, Y.; Sakane, K.

Favourites:
ADD

The Design and Synthesis of Inhibitors of Adenosine 5'-Monophosphate Deaminase
pp. 1985-1990(6)
Authors: Lindell, S.D.; Moloney, B.A.; Hewitt, B.D.; Earnshaw, C.G.; Dudfield, P.J.; Dancer, J.E.

Favourites:
ADD

Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase
pp. 1991-1996(6)
Authors: Ciccarone, T.M.; MacTough, S.C.; Williams, T.M.; Dinsmore, C.J.; O'Neill, T.J.; Shah, D.; Culberson, J.C.; Koblan, K.S.; Kohl, N.E.; Gibbs, J.B.; Oliff, A.I.; Graham, S.L.; Hartman, G.D.

Favourites:
ADD

The synthesis and evaluation of 6-alkylidene-2'-substituted penam sulfones as -lactamase inhibitors
pp. 1997-2002(6)
Authors: Buynak, J.D.; Rao, A.S.; Doppalapudi, V.R.; Adam, G.; Petersen, P.J.; Nidamarthy, S.D.

Favourites:
ADD

Lobophorins A and B, new antiinflammatory macrolides produced by a tropical marine bacterium
pp. 2003-2006(4)
Authors: Jiang, Z.; Jensen, P.R.; Fenical, W.

Favourites:
ADD

The spiroketals containing a benzyloxymethyl moiety at C8 position showed the most potent apoptosis-inducing activity
pp. 2007-2012(6)
Authors: Mitsuhashi, S.; Shima, H.; Kawamura, T.; Kikuchi, K.; Oikawa, M.; Ichihara, A.; Oikawa, H.

Favourites:
ADD

Design and synthesis of a novel synthetic NAPAP-penta-saccharide conjugate displaying a dual antithrombotic action
pp. 2013-2018(6)
Authors: Buijsman, R.C.; Basten, J.E.M.; van Dinther, T.G.; van der Marel, G.A.; van Boeckel, C.A.A.; van Boom, J.H.

Favourites:
ADD

4-hydroxy-5,6-dihydro-2H-pyran-2-ones. 3. bicyclic and heteroaromatic ring systems as 3-position scaffolds to bind to S1' and S2' of the HIV-1 protease enzyme
pp. 2019-2024(6)
Authors: Ellsworth, E.L.; Domagala, J.; Prasad, J.V.N.V.; Hagen, S.; Ferguson, D.; Holler, T.; Hupe, D.; Graham, N.; Nouhan, C.; Tummino, P.J.; Zeikus, G.; Lunney, E.A.

Favourites:
ADD

Synthesis and cytotoxicity of analogues of the antibiotic BE 10988 inhibitors of DNA topoisomerase II
pp. 2025-2030(6)
Authors: Catrycke, M.; Houssin, R.; Henichart, J.; Pfeiffer, B.; Renard, P.; Dassonneville, L.; Bailly, C.

Favourites:
ADD
Favourites:
ADD

Stereoselective Synthesis of a New Muscarinic M3 Receptor Antagonist, J-104129
pp. 2037-2038(2)
Authors: Mitsuya, M.; Kawakami, K.; Ogino, Y.; Miura, K.; Mase, T.

Favourites:
ADD

Polyunsaturated fatty acid anilides as inhibitors of acyl-coa: cholesterol acyltransferase (ACAT)
pp. 2039-2042(4)
Authors: Matsuyama, N.; Kosaka, T.; Fukuhara, M.; Soda, Y.; Mizuno, K.

Favourites:
ADD

Novel carbonic anhydrase isozymes I, II and IV activators incorporating sulfonyl-histamino moieties
pp. 2043-2048(6)
Authors: Briganti, F.; Scozzafava, A.; Supuran, C.T.

Favourites:
ADD
Favourites:
ADD

Design and synthesis of -carboxamido phosphonates as potent inhibitors of imidazole glycerol phosphate dehydratase
pp. 2053-2058(6)
Authors: Schweitzer, B.A.; Loida, P.J.; Thompson-Mize, R.L.; CaJacob, C.A.; Hegde, S.G.

Favourites:
ADD

Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonists
pp. 2059-2064(6)
Authors: Dubuffet, T.; Newman-Tancredi, A.; Cussac, D.; Audinot, V.; Loutz, A.; Millan, M.J.; Lavielle, G.

Favourites:
ADD

Synthesis of Δ4--d-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition
pp. 2065-2068(4)
Authors: Florio, P.; Thomson, R.J.; Alafaci, A.; Abo, S.; von Itzstein, M.

Favourites:
ADD

Synthesis and biological evaluation of analogs of the marine toxin polycavernoside A
pp. 2069-2072(4)
Authors: Barriault, L.; Boulet, S.L.; Fujiwara, K.; Murai, A.; Paquette, L.A.; Yotsu-Yamashita, M.

Favourites:
ADD

Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists
pp. 2073-2078(6)
Authors: Ahn, H.; Arik, L.; Boykow, G.; Burnett, D.A.; Caplen, M.A.; Czarniecki, M.; Domalski, M.S.; Foster, C.; Manna, M.; Stamford, A.W.; Wu, Y.

Favourites:
ADD

Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B
pp. 2079-2084(6)
Authors: Laurin, P.; Ferroud, D.; Klich, M.; Dupuis-Hamelin, C.; Mauvais, P.; Lassaigne, P.; Bonnefoy, A.; Musicki, B.

Favourites:
ADD

C32-O-Phenalkyl ether derivatives of the immunosuppressant ascomycin: a tether length study
pp. 2085-2088(4)
Authors: Goulet, M.T.; Sinclair, P.J.; Wong, F.; Staruch, M.J.; Dumont, F.J.; Cryan, J.G.; Wiederrecht, G.J.; Wyvratt, M.J.; Parsons, W.H.

Favourites:
ADD

Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity
pp. 2089-2094(6)
Authors: Armstrong, H.M.; Wong, F.; Holmes, M.A.; Sinclair, P.J.; Goulet, M.T.; Dumont, F.J.; Staruch, M.; Koprak, S.; Peterson, L.B.; Rosa, R.; Wilusz, M.B.; Wiederrecht, G.J.; Cryan, J.G.; Wyvratt, M.J.; Parsons, W.H.

Favourites:
ADD

Synthesis and evaluation of hydroxyproline-derived isoprenyltransferase inhibitors
pp. 2095-2100(6)
Authors: O'Connell, C.E.; Ackermann, K.; Rowell, C.A.; Garcia, A.M.; Lewis, M.D.; Schwartz, C.E.

Favourites:
ADD

Oxadiazole synthesis on solid supports
pp. 2101-2104(4)
Authors: Liang, G.; Qian, X.

Favourites:
ADD

1[(Benzofuran-2-yl)phenylmethyl]-Triazoles and -Tetrazoles - Potent Competitive Inhibitors of Aromatase
pp. 2105-2108(4)
Authors: Vinh, T.K.; Ahmadi, M.; delgado, P.O.L.; Perez, S.F.; Walters, H.M.; Smith, H.J.; Nicholls, P.J.; Simons, C.

Favourites:
ADD

Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate
pp. 2109-2114(6)
Authors: Jones, A.B.; Acton, J.J.; Rivetna, M.N.; Cummings, R.T.; Cubbon, R.M.; Nichols, E.A.; Schwartz, C.D.; Wicker, L.S.; Hermes, J.D.

Favourites:
ADD

Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands
pp. 2115-2118(4)
Authors: Jones, A.B.; Acton, J.J.; Adams, A.D.; Yuen, W.; Nichols, E.A.; Schwartz, C.D.; Wicker, L.S.; Hermes, J.D.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more